24 January 2017
By Dr Wendy Winnall - PCFA Research Team
In recent years, treatment of metastatic prostate cancer has been greatly improved by the introduction of new drugs. Any new drug has the potential to add more than one option to current treatments. New drugs can be combined with existing therapies, used at different stages of treatment or at different stages of prostate cancer. Each option needs to be specifically tested in clinical trials. This is an expensive and time-consuming process, but these trials do allow more men access to new drugs.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
